Vital KSK Holdings, Inc. (TYO:3151)

Market Cap	62.45B
Revenue (ttm)	603.53B
Net Income (ttm)	9.86B
Shares Out	48.38M
EPS (ttm)	203.76
PE Ratio	6.34
Forward PE	n/a
Dividend	68.00 (5.27%)
Ex-Dividend Date	Mar 30, 2026

Volume	83,800
Average Volume	132,180
Open	1,286.00
Previous Close	1,291.00
Day's Range	1,283.00 - 1,291.00
52-Week Range	1,093.00 - 1,396.00
Beta	0.18
RSI	51.10
Earnings Date	Nov 14, 2025

About Vital KSK Holdings

Vital KSK Holdings, Inc. engages in the wholesale and retail sale of pharmaceutical products in Japan. The company sells poisonous or deleterious substances, narcotics, quasi-drugs, medical equipment and devices, sanitary materials, hygiene goods, nursing care products, and beverages; and test reagents, agricultural chemicals, epidemiological agents and materials, industrial chemicals, veterinary drugs, poisonous and deleterious substances, paints, pigments, dyes, regenerative medicine products, and other chemicals, as well as well as chemicals...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2009
• Employees: 3,756
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 3151

Financial Performance

In 2024, Vital KSK Holdings's revenue was 600.37 billion, an increase of 2.19% compared to the previous year's 587.48 billion. Earnings were 7.31 billion, an increase of 25.07%.